Bifunctional alkylating agent

DRUG CLASS:

Bifunctional alkylating agent

News alerts, weekly reports and conference planners

Related drugs:

‹

›

No biomarker	Testicular Cancer	No biomarker	Testicular Cancer	ifosfamide Sensitive: A1 - Approval ifosfamide Sensitive : A1	ifosfamide Sensitive: A1 - Approval ifosfamide Sensitive : A1
No biomarker	Germ Cell Tumors	No biomarker	Germ Cell Tumors	ifosfamide Sensitive: A1 - Approval ifosfamide Sensitive : A1	ifosfamide Sensitive: A1 - Approval ifosfamide Sensitive : A1
No biomarker	Soft Tissue Sarcoma	No biomarker	Soft Tissue Sarcoma	ifosfamide + epirubicin + mesna Sensitive: A2 - Guideline ifosfamide + epirubicin + mesna Sensitive : A2	ifosfamide + epirubicin + mesna Sensitive: A2 - Guideline ifosfamide + epirubicin + mesna Sensitive : A2
No biomarker	Peritoneal Cancer	No biomarker	Peritoneal Cancer	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2
No biomarker	Peritoneal Cancer	No biomarker	Peritoneal Cancer	paclitaxel + ifosfamide Sensitive: A2 - Guideline paclitaxel + ifosfamide Sensitive : A2	paclitaxel + ifosfamide Sensitive: A2 - Guideline paclitaxel + ifosfamide Sensitive : A2
No biomarker	Peritoneal Cancer	No biomarker	Peritoneal Cancer	cisplatin + ifosfamide Sensitive: A2 - Guideline cisplatin + ifosfamide Sensitive : A2	cisplatin + ifosfamide Sensitive: A2 - Guideline cisplatin + ifosfamide Sensitive : A2
No biomarker	Peritoneal Cancer	No biomarker	Peritoneal Cancer	carboplatin + ifosfamide Sensitive: A2 - Guideline carboplatin + ifosfamide Sensitive : A2	carboplatin + ifosfamide Sensitive: A2 - Guideline carboplatin + ifosfamide Sensitive : A2
No biomarker	Fallopian Tube Cancer	No biomarker	Fallopian Tube Cancer	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2
No biomarker	Fallopian Tube Cancer	No biomarker	Fallopian Tube Cancer	paclitaxel + ifosfamide Sensitive: A2 - Guideline paclitaxel + ifosfamide Sensitive : A2	paclitaxel + ifosfamide Sensitive: A2 - Guideline paclitaxel + ifosfamide Sensitive : A2
No biomarker	Fallopian Tube Cancer	No biomarker	Fallopian Tube Cancer	cisplatin + ifosfamide Sensitive: A2 - Guideline cisplatin + ifosfamide Sensitive : A2	cisplatin + ifosfamide Sensitive: A2 - Guideline cisplatin + ifosfamide Sensitive : A2
No biomarker	Fallopian Tube Cancer	No biomarker	Fallopian Tube Cancer	carboplatin + ifosfamide Sensitive: A2 - Guideline carboplatin + ifosfamide Sensitive : A2	carboplatin + ifosfamide Sensitive: A2 - Guideline carboplatin + ifosfamide Sensitive : A2
No biomarker	Nasopharyngeal Carcinoma	No biomarker	Nasopharyngeal Carcinoma	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2
No biomarker	Thymoma	No biomarker	Thymoma	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2
No biomarker	Sarcoma	No biomarker	Sarcoma	ifosfamide + pegylated liposomal doxorubicin Sensitive: A2 - Guideline ifosfamide + pegylated liposomal doxorubicin Sensitive : A2	ifosfamide + pegylated liposomal doxorubicin Sensitive: A2 - Guideline ifosfamide + pegylated liposomal doxorubicin Sensitive : A2
No biomarker	Sarcoma	No biomarker	Sarcoma	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2
No biomarker	Ovarian Cancer	No biomarker	Ovarian Cancer	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2
No biomarker	Soft Tissue Sarcoma	No biomarker	Soft Tissue Sarcoma	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2
No biomarker	Germ Cell Tumors	No biomarker	Germ Cell Tumors	paclitaxel + ifosfamide Sensitive: A2 - Guideline paclitaxel + ifosfamide Sensitive : A2	paclitaxel + ifosfamide Sensitive: A2 - Guideline paclitaxel + ifosfamide Sensitive : A2
No biomarker	Acute Lymphocytic Leukemia	No biomarker	Acute Lymphocytic Leukemia	ifosfamide + etoposide oral + mitoxantrone Sensitive: A2 - Guideline ifosfamide + etoposide oral + mitoxantrone Sensitive : A2	ifosfamide + etoposide oral + mitoxantrone Sensitive: A2 - Guideline ifosfamide + etoposide oral + mitoxantrone Sensitive : A2
No biomarker	Endometrial Cancer	No biomarker	Endometrial Cancer	cisplatin + ifosfamide Sensitive: A2 - Guideline cisplatin + ifosfamide Sensitive : A2	cisplatin + ifosfamide Sensitive: A2 - Guideline cisplatin + ifosfamide Sensitive : A2
No biomarker	Endometrial Cancer	No biomarker	Endometrial Cancer	paclitaxel + ifosfamide Sensitive: A2 - Guideline paclitaxel + ifosfamide Sensitive : A2	paclitaxel + ifosfamide Sensitive: A2 - Guideline paclitaxel + ifosfamide Sensitive : A2
No biomarker	Endometrial Cancer	No biomarker	Endometrial Cancer	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2
No biomarker	Bladder Cancer	No biomarker	Bladder Cancer	cisplatin + doxorubicin hydrochloride + ifosfamide + etoposide IV Sensitive: A2 - Guideline cisplatin + doxorubicin hydrochloride + ifosfamide + etoposide IV Sensitive : A2	cisplatin + doxorubicin hydrochloride + ifosfamide + etoposide IV Sensitive: A2 - Guideline cisplatin + doxorubicin hydrochloride + ifosfamide + etoposide IV Sensitive : A2
No biomarker	Bladder Cancer	No biomarker	Bladder Cancer	gemcitabine + ifosfamide + pegylated liposomal doxorubicin Sensitive: A2 - Guideline gemcitabine + ifosfamide + pegylated liposomal doxorubicin Sensitive : A2	gemcitabine + ifosfamide + pegylated liposomal doxorubicin Sensitive: A2 - Guideline gemcitabine + ifosfamide + pegylated liposomal doxorubicin Sensitive : A2
No biomarker	Cervical Cancer	No biomarker	Cervical Cancer	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2
No biomarker	Soft Tissue Sarcoma	No biomarker	Soft Tissue Sarcoma	ifosfamide + pegylated liposomal doxorubicin Sensitive: A2 - Guideline ifosfamide + pegylated liposomal doxorubicin Sensitive : A2	ifosfamide + pegylated liposomal doxorubicin Sensitive: A2 - Guideline ifosfamide + pegylated liposomal doxorubicin Sensitive : A2
No biomarker	Ewing Sarcoma	No biomarker	Ewing Sarcoma	cyclophosphamide + ifosfamide + etoposide IV + topotecan Sensitive: A2 - Guideline cyclophosphamide + ifosfamide + etoposide IV + topotecan Sensitive : A2	cyclophosphamide + ifosfamide + etoposide IV + topotecan Sensitive: A2 - Guideline cyclophosphamide + ifosfamide + etoposide IV + topotecan Sensitive : A2
No biomarker	Osteosarcoma	No biomarker	Osteosarcoma	gemcitabine + docetaxel + ifosfamide Sensitive: A2 - Guideline gemcitabine + docetaxel + ifosfamide Sensitive : A2	gemcitabine + docetaxel + ifosfamide Sensitive: A2 - Guideline gemcitabine + docetaxel + ifosfamide Sensitive : A2
No biomarker	Osteosarcoma	No biomarker	Osteosarcoma	carboplatin + ifosfamide + etoposide IV Sensitive: A2 - Guideline carboplatin + ifosfamide + etoposide IV Sensitive : A2	carboplatin + ifosfamide + etoposide IV Sensitive: A2 - Guideline carboplatin + ifosfamide + etoposide IV Sensitive : A2
No biomarker	Osteosarcoma	No biomarker	Osteosarcoma	carboplatin + ifosfamide Sensitive: A2 - Guideline carboplatin + ifosfamide Sensitive : A2	carboplatin + ifosfamide Sensitive: A2 - Guideline carboplatin + ifosfamide Sensitive : A2
No biomarker	Osteosarcoma	No biomarker	Osteosarcoma	cisplatin + doxorubicin hydrochloride + ifosfamide + methotrexate Sensitive: A2 - Guideline cisplatin + doxorubicin hydrochloride + ifosfamide + methotrexate Sensitive : A2	cisplatin + doxorubicin hydrochloride + ifosfamide + methotrexate Sensitive: A2 - Guideline cisplatin + doxorubicin hydrochloride + ifosfamide + methotrexate Sensitive : A2

Bifunctional alkylating agent

Bifunctional alkylating agent

Associations(59)

Associations
(59)